APO Research
Talk to an analyst

APO RESEARCH · REPORT

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026193 pages

Choose your research edition.

Industry ResearchInduced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit include INNOBIO, Cellapy, Merck, Thermo Fisher, REPROCELL, Qurgen, Bio-Techne, Applied StemCell and ALSTEM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Company

INNOBIO

Cellapy

Merck

Thermo Fisher

REPROCELL

Qurgen

Bio-Techne

Applied StemCell

ALSTEM

Abcam

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Type

Feeder Based Reprogramming

Feeder-free Based Reprogramming

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Application

Life Science and Medical Research Colleges (Institutes)

Biotechnology Company

Biomedical Pharmaceutical Factory

Hospital Clinical Research Institution

Others

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Trends Table 2. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Drivers Table 3. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Opportunities and Challenges Table 4. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Restraints Table 5. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Manufacturers Table 9. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Manufacturers, Product Type & Application Table 13. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Feeder Based Reprogramming Table 17. Major Manufacturers of Feeder-free Based Reprogramming Table 18. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 20. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2027-2032) & (k units) Table 21. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Type (2021-2026) Table 22. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Type (2027-2032) Table 23. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type (2021-2026) & (k units) Table 25. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type (2027-2032) & (k units) Table 26. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Type (2021-2026) Table 27. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Life Science and Medical Research Colleges (Institutes) Table 29. Major Manufacturers of Biotechnology Company Table 30. Major Manufacturers of Biomedical Pharmaceutical Factory Table 31. Major Manufacturers of Hospital Clinical Research Institution Table 32. Major Manufacturers of Others Table 33. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 35. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2027-2032) & (k units) Table 36. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Application (2021-2026) Table 37. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Application (2027-2032) Table 38. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application (2021-2026) & (k units) Table 40. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application (2027-2032) & (k units) Table 41. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Application (2021-2026) Table 42. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Application (2027-2032) Table 43. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2021-2026) & (k units) Table 45. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Region (2021-2026) Table 46. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 50. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2027-2032) & (k units) Table 51. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 53. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2027-2032) & (k units) Table 60. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Region (2021-2026) Table 64. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Region (2027-2032) Table 65. INNOBIO Company Information Table 66. INNOBIO Business Overview Table 67. INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 69. INNOBIO Recent Development Table 70. Cellapy Company Information Table 71. Cellapy Business Overview Table 72. Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 74. Cellapy Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 79. Merck Recent Development Table 80. Thermo Fisher Company Information Table 81. Thermo Fisher Business Overview Table 82. Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 84. Thermo Fisher Recent Development Table 85. REPROCELL Company Information Table 86. REPROCELL Business Overview Table 87. REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 89. REPROCELL Recent Development Table 90. Qurgen Company Information Table 91. Qurgen Business Overview Table 92. Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 94. Qurgen Recent Development Table 95. Bio-Techne Company Information Table 96. Bio-Techne Business Overview Table 97. Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 99. Bio-Techne Recent Development Table 100. Applied StemCell Company Information Table 101. Applied StemCell Business Overview Table 102. Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 104. Applied StemCell Recent Development Table 105. ALSTEM Company Information Table 106. ALSTEM Business Overview Table 107. ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 109. ALSTEM Recent Development Table 110. Abcam Company Information Table 111. Abcam Business Overview Table 112. Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 114. Abcam Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Distributors List Table 118. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Image Figure 2. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (2021-2032) & (k units) Figure 5. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Feeder Based Reprogramming Image Figure 9. Feeder-free Based Reprogramming Image Figure 10. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Type (2021-2032) Figure 13. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Type (2021-2032) Figure 16. Life Science and Medical Research Colleges (Institutes) Image Figure 17. Biotechnology Company Image Figure 18. Biomedical Pharmaceutical Factory Image Figure 19. Hospital Clinical Research Institution Image Figure 20. Others Image Figure 21. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Application (2021-2032) Figure 24. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Application (2021-2032) Figure 27. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2032) Figure 29. U.S. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2032) Figure 34. Germany Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2032) Figure 41. China Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2032) Figure 49. Brazil Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032) & (US$ Million) Figure 60. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032) & (US$ Million) Figure 62. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Feeder Based Reprogramming
  • Feeder-free Based Reprogramming
Applications
  • Life Science and Medical Research Colleges (Institutes)
  • Biotechnology Company
  • Biomedical Pharmaceutical Factory
  • Hospital Clinical Research Institution
  • Others
Companies covered
  • INNOBIO
  • Cellapy
  • Merck
  • Thermo Fisher
  • REPROCELL
  • Qurgen
  • Bio-Techne
  • Applied StemCell
  • ALSTEM
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Dynamics
  1. 2.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Trends
  2. 2.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Drivers
  3. 2.3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Opportunities and Challenges
  4. 2.4 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Restraints
3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Manufacturers
  1. 3.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Manufacturers (2021-2026)
  3. 3.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Manufacturers, Product Type & Application
  7. 3.7 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Tier 1, Tier 2, and Tier 3
4 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Type
  1. 4.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Type Introduction
  2. 4.1.1 Feeder Based Reprogramming
  3. 4.1.2 Feeder-free Based Reprogramming
  4. 4.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type
  5. 4.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2032)
  7. 4.2.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Type (2021-2032)
  8. 4.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type
  9. 4.3.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Type (2021-2032)
  11. 4.3.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Type (2021-2032)
5 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Application
  1. 5.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Application Introduction
  2. 5.1.1 Life Science and Medical Research Colleges (Institutes)
  3. 5.1.2 Biotechnology Company
  4. 5.1.3 Biomedical Pharmaceutical Factory
  5. 5.1.4 Hospital Clinical Research Institution
  6. 5.1.5 Others
  7. 5.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application
  8. 5.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2032)
  10. 5.2.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Application (2021-2032)
  11. 5.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application
  12. 5.3.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Application (2021-2032)
  14. 5.3.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Application (2021-2032)
6 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region
  1. 6.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2021-2026)
  4. 6.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region
  1. 7.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region
  2. 7.1.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region (2021-2026)
  4. 7.1.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue by Region (2027-2032)
  5. 7.1.4 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032)
  8. 7.2.2 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032)
  11. 7.3.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 INNOBIO
  2. 8.1.1 INNOBIO Company Information
  3. 8.1.2 INNOBIO Business Overview
  4. 8.1.3 INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  6. 8.1.5 INNOBIO Recent Developments
  7. 8.2 Cellapy
  8. 8.2.1 Cellapy Company Information
  9. 8.2.2 Cellapy Business Overview
  10. 8.2.3 Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  12. 8.2.5 Cellapy Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Thermo Fisher
  20. 8.4.1 Thermo Fisher Company Information
  21. 8.4.2 Thermo Fisher Business Overview
  22. 8.4.3 Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  24. 8.4.5 Thermo Fisher Recent Developments
  25. 8.5 REPROCELL
  26. 8.5.1 REPROCELL Company Information
  27. 8.5.2 REPROCELL Business Overview
  28. 8.5.3 REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  30. 8.5.5 REPROCELL Recent Developments
  31. 8.6 Qurgen
  32. 8.6.1 Qurgen Company Information
  33. 8.6.2 Qurgen Business Overview
  34. 8.6.3 Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  36. 8.6.5 Qurgen Recent Developments
  37. 8.7 Bio-Techne
  38. 8.7.1 Bio-Techne Company Information
  39. 8.7.2 Bio-Techne Business Overview
  40. 8.7.3 Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  42. 8.7.5 Bio-Techne Recent Developments
  43. 8.8 Applied StemCell
  44. 8.8.1 Applied StemCell Company Information
  45. 8.8.2 Applied StemCell Business Overview
  46. 8.8.3 Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  48. 8.8.5 Applied StemCell Recent Developments
  49. 8.9 ALSTEM
  50. 8.9.1 ALSTEM Company Information
  51. 8.9.2 ALSTEM Business Overview
  52. 8.9.3 ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  54. 8.9.5 ALSTEM Recent Developments
  55. 8.10 Abcam
  56. 8.10.1 Abcam Company Information
  57. 8.10.2 Abcam Business Overview
  58. 8.10.3 Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  60. 8.10.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Value Chain Analysis
  2. 9.1.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Production Mode & Process
  6. 9.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Distributors
  9. 9.2.3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst